ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 40 filers reported holding ENOCHIAN BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $94,777 | +1213.6% | 21,203 | +66.5% | 0.00% | – |
Q2 2023 | $7,215 | -38.1% | 12,734 | -0.1% | 0.00% | – |
Q1 2023 | $11,660 | +89592.3% | 12,742 | -0.1% | 0.00% | – |
Q4 2022 | $13 | -100.0% | 12,754 | -37.6% | 0.00% | – |
Q3 2022 | $37,000 | -66.7% | 20,442 | -64.5% | 0.00% | – |
Q2 2022 | $111,000 | -79.7% | 57,545 | -13.4% | 0.00% | – |
Q1 2022 | $548,000 | -6.8% | 66,431 | -17.7% | 0.00% | – |
Q4 2021 | $588,000 | +8.3% | 80,675 | 0.0% | 0.00% | – |
Q3 2021 | $543,000 | +35.1% | 80,675 | -0.2% | 0.00% | – |
Q2 2021 | $402,000 | +33.6% | 80,825 | -4.8% | 0.00% | – |
Q1 2021 | $301,000 | +59.3% | 84,921 | +32.4% | 0.00% | – |
Q4 2020 | $189,000 | -17.8% | 64,149 | +0.0% | 0.00% | – |
Q3 2020 | $230,000 | -14.8% | 64,141 | 0.0% | 0.00% | – |
Q2 2020 | $270,000 | +40.6% | 64,141 | 0.0% | 0.00% | – |
Q1 2020 | $192,000 | -38.3% | 64,141 | +3.4% | 0.00% | – |
Q4 2019 | $311,000 | -13.4% | 62,041 | -5.1% | 0.00% | – |
Q3 2019 | $359,000 | +22.1% | 65,341 | 0.0% | 0.00% | – |
Q2 2019 | $294,000 | +297.3% | 65,341 | +514.2% | 0.00% | – |
Q1 2019 | $74,000 | – | 10,638 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Leucadia National | 16,600 | $74,202 | 0.00% |
Cubist Systematic Strategies, LLC | 10,901 | $48,727 | 0.00% |
UBS Group AG | 6,022 | $26,918 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 3,395 | $15,176 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 21,203 | $94,777 | 0.00% |
BANK OF AMERICA CORP /DE/ | 1,780 | $7,957 | 0.00% |
WELLS FARGO & COMPANY/MN | 214 | $956 | 0.00% |
NORTHERN TRUST CORP | 59,804 | $267,324 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 303,094 | $1,355,169 | 0.00% |